Tranexamsyrapulver

Viktiga fördelar med tranexamsyrapulver

• Exakt riktad mekanism By competitively inhibiting plasminogen activation, it stabilizes blood clots, achieving highly effective hemostasis without directly activating the coagulation system, thereby reducing the risk of systemic thrombosis.
• Evidensbaserad och auktoritativ rekommendation Included in the World Health Organization’s List of Essential Medicines and highly recommended in clinical guidelines across multiple fields, including orthopedics, obstetrics and gynecology, and trauma surgery, it effectively reduces the need for blood transfusions during surgery and lowers trauma mortality rates.
• Utökade multifunktionella fördelar It combines skin-lightening properties for treating melasma with anti-inflammatory effects, offers good overall safety, and is rarely associated with serious adverse reactions.

Effekter av tranexamsyrapulver

• Mycket effektiv hemostas By stabilizing fibrin clots through its antifibrinolytic action, it significantly reduces perioperative blood loss and lowers the need for allogeneic blood transfusions; it can significantly improve the survival rate of patients with severe hemorrhage.
• Hantering av specifika villkor Denna medicin godsaker menorrhagia, severe epistaxis, and hemoptysis; it also förhindrar blödning efter extraktion hos hemofilipatienter och sekundär blödning efter traumatisk främre kammarblödning
• Hudblekare och antiinflammation By inhibiting melanocyte activation signals, it improves melasma and post-inflammatory hyperpigmentation; simultaneously, by reducing vascular permeability, it provides adjunctive treatment for hereditary angioedema, urticaria, and similar conditions.

Heavy Metals (Chemical Control)

Mikrobiologiska tester